BRAF/MEK inhibitors use to treat ventriculoperitoneal shunt-associated ascites in pediatric low-grade gliomas.
Nisreen AmayiriMouness ObeidatDima Abu LabanAwni MusharbashMaysa Al-HussainiBayan MaraqaAhmadKh IbrahimiNasim SarhanEric BouffetPublished in: Pediatric blood & cancer (2024)